Cystectomy Clinical Trials

Clinical trials related to Cystectomy Procedure

Trop2-Targeted NIR-II Fluorescent Probe for Identifying Bladder Cancer in Ex Vivo Bladder Samples

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

Up to 30% of non-muscle-invasive bladder cancer (NMIBC) lesions may be missed by standard white-light cystoscopy, resulting in high tumor recurrence rate. This is a single-center, single-arm, phase 2 prospective study. We apply Trop2-targeted NIR-II fluorescent probe TTP-ICG with rapid incubation to ex vivo bladder specimens from patients undergoing radical cystectomy. Near-infrared fluorescence imaging is performed after short-time incubation and washing. Using histopathology as gold standard, we evaluate the sensitivity, specificity of this imaging system for identifying bladder cancer lesions, and analyze correlation between fluorescence intensity and pathological diagnosis. 30 subjects will be enrolled.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Suspected or confirmed bladder tumor patients who are scheduled to undergo radical cystectomy.

• Able to provide written informed consent and comply with study protocol.

Locations
Other Locations
China
Yunnan Cancer Hospital
RECRUITING
Kunming
Contact Information
Primary
Shengjie Lin, Doctor of Medicine
Linshengjie1128@163.com
86+17850112800
Time Frame
Start Date: 2026-08-01
Estimated Completion Date: 2027-08-30
Participants
Target number of participants: 30
Treatments
Experimental: TTP-ICG ex-vivo rapid incubation fluorescence imaging
Related Therapeutic Areas
Sponsors
Leads: Yunnan Cancer Hospital

This content was sourced from clinicaltrials.gov